Neuronetics (STIM)
(Real Time Quote from BATS)
$1.72 USD
-0.08 (-4.44%)
Updated Aug 5, 2024 10:38 AM ET
3-Hold of 5 3
C Value F Growth B Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
STIM 1.72 -0.08(-4.44%)
Will STIM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for STIM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for STIM
Integra LifeSciences (IART) Q2 Earnings and Revenues Surpass Estimates
Neuronetics (STIM) Expands NeuroStar Portfolio With New Launch
STIM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates
Neuronetics' (STIM) FDA-Cleared NeuroStar to Aid in Depression
Neuronetics (STIM) Progresses in MRD and TRD With New Deal
Other News for STIM
NeuroStar Partners With This Is My Brave to Recognize Teen Mental Health Month
Neuronetics partners with non-profit This Is My Brave
Neuronetics to Present at the Canaccord Genuity 44th Annual Growth Conference
Neuronetics Announces the Closing of up to $90 Million Senior Secured Credit Facility with Perceptive Advisors
Neuronetics’ New $90 Million Credit Facility and Strategic Financial Moves